Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Biomedicines|January 28, 2026
Menin Inhibition in Acute Myeloid Leukemia: Pathobiology, Progress and PromiseUtsav Joshi, Rory M ShallisHematology Reports|November 24, 2025
MECOM-Rearranged Acute Myeloid Leukemia: Pathobiology and Management StrategiesUtsav Joshi, Rory M ShallisFrontiers in Cell and Developmental Biology|April 3, 2026
Mechanistic overview and suggested strategies to overcome BCL-2 inhibitor resistance in TP53-mutated acute myeloid leukemiaUmar Iqbal, Rory M ShallisCurrent Opinion in Hematology|January 4, 2021
Maintenance therapy for acute myeloid leukemia: sustaining the pursuit for sustained remissionRory M Shallis, Nikolai A PodoltsevBMC Hematology|February 14, 2018
More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromesRory M Shallis, Amer M ZeidanBiomarker Research|May 29, 2021
Emerging agents and regimens for polycythemia vera and essential thrombocythemiaRory M Shallis, Nikolai A PodoltsevLeukemia & Lymphoma|February 2, 2022
Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesisRory M Shallis, Steven D GoreBest Practice & Research. Clinical Haematology|May 29, 2020
Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term?Rory M Shallis, Amer M ZeidanDrugs & Aging|August 3, 2021
Management of the Older Patient with Myelodysplastic SyndromeRory M Shallis, Amer M ZeidanEuropean Journal of Haematology|May 10, 2018
The genetic and molecular pathogenesis of myelodysplastic syndromesRory M Shallis, Rami Ahmad, Amer M ZeidanPageof 10